Nureca revenue rises 34% to ₹1,469.93 crore in FY26

1 min read Updated on 04 Jul 2026, 12:17 AM

Reviewed by

Shriram SScanX News Team

AI Summary

Nureca Limited reported a 34.02% increase in revenue from operations to ₹1,469.93 crore for the year ended March 31, 2026. Profit after tax rose 146.10% to ₹20.82 crore, while EBITDA grew 68.94% to ₹82.78 million. The company achieved an operational turnaround with an operating profit of ₹8.5 crore compared to a loss in the previous year.

*this image is generated using AI for illustrative purposes only.

Financial Performance

The company delivered a significant operational turnaround in FY26, posting an operating profit of ₹8.5 crore compared to an operating loss of ₹7.5 crore in FY25. This turnaround was driven by enhanced operational efficiencies after three consecutive years of losses. However, the company reported a loss for the current quarter (Q4 FY26) due to a fair value loss on investments.

Metric	FY 2025-26	FY 2024-25	Change
Revenue from operations (₹ in million)	1,469.93	1,096.61	34.02%
EBITDA (₹ in million)	82.78	49.00	68.94%
Profit after tax (₹ in million)	20.82	8.46	146.10%

Operational Highlights

Gross merchandise value (GMV) for the year stood at ₹2,029.86 million, an increase of 17.51% from ₹1,730 million in FY25. The EBITDA margin improved to 5.63% in FY26 from 4% in FY25. Net profit margins also improved to 1.47% from 1.07% in the previous year.

Corporate Developments

The Board of Directors has recommended the re-appointment of Mr. Saurabh Goyal as Chairman & Managing Director for a period of three years with effect from September 3, 2026. Additionally, the Board has recommended the appointment of Ms. Smita Goyal as a Whole-time Director for a period of three years with effect from June 01, 2026.

The company’s wholly-owned subsidiary, Nureca Healthcare Private Limited, was dissolved and struck off from the Register of Companies with effect from December 3, 2025.

Historical Stock Returns for Nureca

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+12.01%	+20.10%	+18.51%	-3.16%	-4.04%	-82.96%

How will the company sustain its operational turnaround into FY27 given the Q4 loss driven by investment fair value fluctuations?

What specific operational efficiency measures were implemented to reverse three consecutive years of losses?

What are the strategic implications of dissolving the wholly-owned subsidiary, Nureca Healthcare Private Limited?

Read Next Article

Nureca Limited to hold 10th AGM on July 28, 2026

0 min read Updated on 03 Jul 2026, 08:27 PM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

AI Summary

Nureca Limited will hold its 10th AGM on July 28, 2026, via VC/OAVM. Key agendas include adopting financial statements and re-appointing directors.

*this image is generated using AI for illustrative purposes only.

Nureca Limited has scheduled its 10th Annual General Meeting (AGM) for July 28, 2026, at 11:30 AM. The meeting will be held through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), with the registered office deemed as the venue.

The primary agenda includes the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. Shareholders will also consider the re-appointment of Mr. Rajinder Sharma (DIN: 00317133) as a Director, who retires by rotation and is eligible for re-appointment.

Additionally, the meeting will seek shareholder approval for the re-appointment of Mr. Saurabh Goyal (DIN: 00136037) as Managing Director for a period of three years effective September 3, 2026. The Board has recommended the resolutions for approval by the members.

Historical Stock Returns for Nureca